Acceder
  1. Inicio
  2. Perfil de raclit
  3. Contenidos recomendados por raclit

Contenidos recomendados por raclit

raclit 23/10/12 15:14
Ha respondido al tema Farmas USA
Artículo de chimera sobre EXEL, explicando un poco el tema como está y lo que viene en noviembre http://www.chimeraresearchgroup.com/2012/10/exel-looking-for-direction-ahead-of-the-pdufa-date/ "The first resistance line is the $5.08 line that acted as a resistance line several times, followed by the gap filling line @ $5.57, while the weekly resistance line @ $5.81 is the strongest one in case we have a breakout ahead of the PDUFA date, so we might see a testing of the last high at $6.95 again."
Ir a respuesta
raclit 23/10/12 13:38
Ha respondido al tema Farmas USA
aqui tienes una que está aun en la cuba de fermentación, no es ni vino aun!! http://www.dailypolitical.com/finance/stock-market/janney-montgomery-scott-gives-buy-rating-to-office-depot-odp.htm ODP
Ir a respuesta
raclit 22/10/12 19:38
Ha respondido al tema Threshold Pharmaceuticals, Inc (THLD): Opiniones
Vaya semanita/as con thld, reflexionando un poco 1. por un lado, tenemos las palabras de enola que creo que a todos nos tranquiliza para ir a medio/largo, bajada por cierre de cortos y a esperar la subida "sin problemas" que comentó de nuevo sobre los 7,5. El tema es que de momento no los está recuperando tan rápido, y rompiendo los 5 que ya preocupa a más de uno 2. En principio va todo según los previsto, no hay bajadas de PO ni malas noticias, las casas más conservadoras Lazard y Mizhuo siguen ahi, ni se mueven, si hubieran malas noticias ¿no creeis que lo bajarian? 3. buscando he encontrado este texto que saco de un post, y que con la info que tenemos, pienso que puede resumir lo que está pasando "It is simply that short-term investor have sold out and are going off to find the next hot stock. If so, volatility should subside and we'll see some northward move in the stock price, and a return to normalcy. Shortly, we'll get 3Q earnings. Then we should see an investor presentation somewhere. Hope Selick can find some fresh content. In late November or December we’ll get a round of trial news." Esperemos que en breve vaya la cosa bien y ánimooo!! __________________ Extractos de frases de diferentes posts, son opiniones de gente como nosotros dijéramos, pero yo encuentro sentido en ellas "The only thing that has changed is more good news coming out . The latest is Phase 3 pancreatic conducted by Merk with a SPA from the FDA" "The so-called big guys that originally invested in the stock (Fidelity and Baker Bros., for example) are still holding the stock. It's only the traders out to make a quick buck that are driving the price action (include the Hedge Funds in this). There are no fundamental problems with this company. If there were they would have been announced and the stock price would have plummeted in a single day. This is like a slow train wreck, with the stock price dropping day after day" "I'm hanging in there because THLD has been very successful to date and has the funds on hand to develope their test programs without the need for additional funding.With $100 million in the bank by years end and a market capitalization of $260 million at this depressed price, the cash represents 38% of the market cap. What's not to like?"
Ir a respuesta
raclit 20/10/12 18:04
Ha respondido al tema Threshold Pharmaceuticals, Inc (THLD): Opiniones
-----opinion sacada de foro----- This is the future of cancer treatment. TH-302 fits in any combination of the above including radiation. This approach ignites the competition for safer treatments that can be used with antiangeogenics and radiation. Abraxanne and Folfiranox are designed with the last ( Gem ) generation approach for cancer therapy. Abx and Folfiranox is not the future, but will become obsolete within a decades time. Attacking fast growing and mutating cancer cells only buys time. The key is to slow the growth and deliver a drug that can penetrate areas ( hypoxic ) to selectively kill cancerous cells, thereby shrinking and eventually eliminating tumors.
Ir a respuesta
raclit 18/10/12 18:51
Ha respondido al tema Farmas USA
irrelevante lo anterior, que se da en todos o casi todos los valores del nasdaq, seran fondos o algo similar digo yo..
Ir a respuesta
raclit 18/10/12 18:44
Ha respondido al tema Farmas USA
como curiosidad, se dan dos movimentos fuertes a última última hora iguales en varias Acciones AMRN 16:00:00 $ 10.93 18,140 16:00:00 $ 10.93 18,140 THLD 16:00:00 $ 5.10 16,721 16:00:00 $ 5.10 16,721 ARNA 16:00:00 $ 9.54 50,386 16:00:00 $ 9.54 50,386 CLSN 16:00:00 $ 4.93 33,900 16:00:00 $ 4.93 33,900
Ir a respuesta
raclit 15/10/12 18:31
Ha respondido al tema Farmas USA
CLSN, insider comprando http://secfilings.com/searchresultswide.aspx?link=1&filingid=8863875
Ir a respuesta
raclit 14/10/12 15:55
Ha respondido al tema Farmas USA
ya decia yo... actualizar lo han actualizado hace poco, pero como se ve mal, ya no me fio de finviz para este dato, ala..jaja ;-) he buscado en otro, este está más completo http://openinsider.com/search?q=odp
Ir a respuesta
raclit 13/10/12 05:27
Ha respondido al tema Farmas USA
ODP http://marketbrief.com/odp/form4/insider-trading/2012/10/11/9771203?s=st
Ir a respuesta